As of 2026-03-22, the Relative Valuation of Cortexyme Inc (CRTX) is (29.50) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.95 USD, the upside of Cortexyme Inc based on Relative Valuation is -1613.0%.
The range of the Relative Valuation is (26.52) - (31.49) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 25.3x | 22.2x |
| Forward P/E multiples | 19.4x - 23.1x | 21.1x |
| Fair Price | (26.52) - (31.49) | (29.50) |
| Upside | -1460.1% - -1714.8% | -1613.0% |
| Date | P/E |